Abstract 325: Development of the pyridopyrimidine derivative KC12 as a selective dual Pim/Mnk inhibitor to inhibit leukemia cell growth.
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institution: Shenyang Pharmaceutical University
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7148832278
Cites:
Cited by:
Related to: